La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Biora Therapeutics Gestione
Gestione criteri di controllo 3/4
Biora Therapeutics' CEO is Adi Mohanty, appointed in Nov 2021, has a tenure of 2.75 years. total yearly compensation is $3.14M, comprised of 18.3% salary and 81.7% bonuses, including company stock and options. directly owns 4.03% of the company’s shares, worth $967.37K. The average tenure of the management team and the board of directors is 2.5 years and 3.2 years respectively.
Informazioni chiave
Adi Mohanty
Amministratore delegato
US$3.1m
Compenso totale
Percentuale dello stipendio del CEO | 18.3% |
Mandato del CEO | 2.8yrs |
Proprietà del CEO | 4.0% |
Durata media del management | 2.5yrs |
Durata media del Consiglio di amministrazione | 3.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Biora Therapeutics granted patent for oral delivery of GLP-1 receptor agonists
Sep 13Biora Therapeutics: Checking In On The Transformation
Aug 17Biora rallies 30%, highest since November on data for drug delivery device
Aug 10Progenity: Analyzing The Huge Paradigm Shift
Dec 20Progenity: Transformation Raises Questions
Oct 03Progenity on a roller coaster ride since strategic transformation announcement
Jun 09Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$87m |
Mar 31 2024 | n/a | n/a | -US$111m |
Dec 31 2023 | US$3m | US$574k | -US$124m |
Sep 30 2023 | n/a | n/a | -US$122m |
Jun 30 2023 | n/a | n/a | -US$64m |
Mar 31 2023 | n/a | n/a | -US$52m |
Dec 31 2022 | US$4m | US$550k | -US$49m |
Sep 30 2022 | n/a | n/a | -US$118m |
Jun 30 2022 | n/a | n/a | -US$140m |
Mar 31 2022 | n/a | n/a | -US$176m |
Dec 31 2021 | US$10m | US$63k | -US$179m |
Compensazione vs Mercato: Adi's total compensation ($USD3.14M) is above average for companies of similar size in the US market ($USD680.04K).
Compensazione vs guadagni: Adi's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Adi Mohanty (57 yo)
2.8yrs
Mandato
US$3,139,017
Compensazione
Mr. Aditya P. Mohanty, also known as Adi,M.B.A. serves as Chief Executive Officer and Director at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) since November 8, 2021. Mr. Mohanty founded En...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Director | 2.8yrs | US$3.14m | 4.03% $ 967.4k | |
Chief Financial Officer | 5.3yrs | US$1.60m | 1.58% $ 379.3k | |
Senior VP | 9.9yrs | US$1.53m | 1.28% $ 306.7k | |
VP of Finance & Accounting & Treasurer | no data | Nessun dato | Nessun dato | |
Senior Vice President of Sales | 4.8yrs | Nessun dato | Nessun dato | |
Head of Human Resources | no data | Nessun dato | Nessun dato | |
Senior VP of Strategic Operations | no data | Nessun dato | Nessun dato | |
Head of Research | 2.3yrs | Nessun dato | Nessun dato | |
Head of Technical Operations | 2.3yrs | Nessun dato | Nessun dato | |
Chief Medical Officer | 1.3yrs | Nessun dato | Nessun dato | |
Head of Business Development | less than a year | Nessun dato | Nessun dato |
2.5yrs
Durata media
60yo
Età media
Gestione esperta: BIOR's management team is considered experienced (2.5 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Director | 2.8yrs | US$3.14m | 4.03% $ 967.4k | |
Independent Director | 5.2yrs | US$185.11k | 0.050% $ 12.0k | |
Member of Clinical Advisory Board SIBO & Functional Bowel Disorders | no data | Nessun dato | Nessun dato | |
Member of Clinical Advisory Board SIBO & Functional Bowel Disorders | no data | Nessun dato | Nessun dato | |
Member of Inflammatory Bowel Disease Clinical Advisory Board | 3.2yrs | Nessun dato | Nessun dato | |
Chairman of Inflammatory Bowel Disease Clinical Advisory Board | 3.2yrs | Nessun dato | Nessun dato | |
Independent Chairman | 5.6yrs | US$208.11k | 0.052% $ 12.5k | |
Member of Clinical Advisory Board - SIBO & Functional Bowel Disorders | no data | Nessun dato | Nessun dato | |
Independent Director | 5.5yrs | US$163.11k | 0.050% $ 12.0k | |
Member of Inflammatory Bowel Disease Clinical Advisory Board | 3.2yrs | Nessun dato | Nessun dato | |
Independent Director | 2.8yrs | US$180.11k | 0.049% $ 11.8k | |
Chair of Clinical Advisory Board-SIBO/Functional Bowel Disorders | no data | Nessun dato | Nessun dato |
3.2yrs
Durata media
57yo
Età media
Consiglio di amministrazione esperto: BIOR's board of directors are considered experienced (3.2 years average tenure).